A detailed history of Assenagon Asset Management S.A. transactions in Glaukos Corp stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 75,798 shares of GKOS stock, worth $11.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
75,798
Previous 57,731 31.3%
Holding current value
$11.4 Million
Previous $6.83 Million 44.53%
% of portfolio
0.02%
Previous 0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$113.62 - $135.39 $2.05 Million - $2.45 Million
18,067 Added 31.3%
75,798 $9.87 Million
Q2 2024

Jul 18, 2024

BUY
$89.48 - $118.35 $5.17 Million - $6.83 Million
57,731 New
57,731 $6.83 Million
Q4 2022

Jan 12, 2023

BUY
$40.82 - $57.75 $1.8 Million - $2.54 Million
43,988 Added 347.1%
56,661 $2.48 Million
Q3 2022

Oct 27, 2022

SELL
$46.84 - $58.49 $41.6 Million - $51.9 Million
-887,435 Reduced 98.59%
12,673 $675,000
Q2 2022

Jul 27, 2022

BUY
$34.86 - $63.77 $26.3 Million - $48 Million
753,348 Added 513.32%
900,108 $40.9 Million
Q1 2022

Apr 25, 2022

SELL
$44.33 - $57.82 $4.79 Million - $6.25 Million
-108,083 Reduced 42.41%
146,760 $8.49 Million
Q4 2021

Feb 01, 2022

BUY
$40.27 - $56.99 $10.3 Million - $14.5 Million
254,843 New
254,843 $11.3 Million
Q2 2021

Jul 15, 2021

SELL
$73.06 - $97.7 $5.44 Million - $7.28 Million
-74,479 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$70.43 - $97.42 $5.25 Million - $7.26 Million
74,479 New
74,479 $6.25 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.